AI in Drug Discovery: Milestones, Limitations and the Push for Clinically Relevant Data
AI is transforming drug discovery across target ID, molecule design and trial optimization. Milestones include regulatory qualification of digital-twin controls and positive Phase 2a data, though 90-95% of candidates still fail.